Double-blind studies are crucial in cancer research for several reasons. First, they help to eliminate bias, ensuring that the outcomes are solely due to the treatment rather than the expectations of the participants or the researchers. Second, they provide a higher level of evidence, which is essential when evaluating the efficacy and safety of new cancer therapies.